Regulation of angiogenesis by macrophages

Advances in Experimental Medicine and Biology

Volumn 664, Issue , 2010, Pages 15-19

  Apte, Rajendra S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A;

ANGIOGENESIS; CELL CULTURE; CONFERENCE PAPER; DIABETIC RETINOPATHY; IMMUNE RESPONSE; INNATE IMMUNITY; MACROPHAGE; NONHUMAN; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; RETINA BLOOD VESSEL; RETINA MACULA AGE RELATED DEGENERATION; RETROLENTAL FIBROPLASIA; SIGNAL TRANSDUCTION; SUBRETINAL NEOVASCULARIZATION; VISION;

ANIMALS; CELL POLARITY; HUMANS; MACROPHAGES; NEOVASCULARIZATION, PATHOLOGIC;

EID: 77955600434     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-1399-9_2     Document Type: Conference Paper

References (24)

1. Ambati J, Anand A, Fernandez S et al (2003) An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat Med 9:1390-1397 (Pubitemid 37466188)
2. Apte RS,Mayhew E, Niederkorn JY (1997) Local inhibition of natural killer cell activity promotes the progressive growth of intraocular tumors. Invest Ophthalmol Vis Sci 38:1277-1282 (Pubitemid 27227058)
3. Apte RS, Niederkorn JY (1996) Isolation and characterization of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye. J Immunol 156:2667-2673 (Pubitemid 126660609)
4. Apte RS, Richter J, Herndon J et al (2006) Macrophages inhibit neovascularization in a murine model of age-related macular degeneration. PLoS Med 3:310-320
5. Brown DM, Kaiser PK, Michels M et al (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355:1432-1444 (Pubitemid 44511558)
6. Dace DS, Khan AA, Kelly J et al (2008) Interleukin-10 promotes pathological angiogenesis by regulating macrophage response to hypoxia during development. PLoS ONE 3:e3381
7. Edwards AO, Ritter R 3rd, Abel KJ et al (2005) Complement factor H polymorphism and agerelated macular degeneration. Science 308:421-424 (Pubitemid 40530082)
8. Espinosa-Heidmann DG, Suner I, Hernandez EP et al (2002) Age as an independent risk factor for severity of experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 43: 1567-1573 (Pubitemid 34462659)
9. Espinosa-Heidmann DG, Suner IJ, Hernandez EP et al (2003) Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 44:3586-3592 (Pubitemid 36909799)
10. Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685-1695
11. Kaplan HJ, Leibole MA, Tezel T et al (1999) Fas ligand (CD95 ligand) controls angiogenesis beneath the retina. Nat Med 5:292-297 (Pubitemid 29124364)
12. Kelly J, Khan AA, Yin J et al (2007) Senescence regulates macrophage activation and angiogenic fate at sites of tissue injury in mice. J Clin Invest 117:3421-3426 (Pubitemid 350096997)
13. Klein R, Peto T, Bird A et al (2004) The epidemiology of age-related macular degeneration. Am J Ophthalmol 137:486-495 (Pubitemid 38328641)
14. Lin HH, Faunce DE, Stacey M et al (2005) The macrophage F4/80 receptor is required for the induction of antigen-specific efferent regulatory T cells in peripheral tolerance. J Exp Med 201:1615-1625 (Pubitemid 40721005)
15. Lobov IB, Rao S, Carroll TJ et al (2005) WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nature 437:417-421 (Pubitemid 41613504)
16. Mosser DM (2003) The many faces of macrophage activation. J Leukoc Biol 73:209-212 (Pubitemid 36158295)
17. Nakao S, Kuwano T, Tsutsumi-Miyahara C et al (2005) Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1beta-induced neovascularization and tumor growth. J Clin Invest 115:2979-2991 (Pubitemid 41567564)
18. Niederkorn JY (2006) See no evil, hear no evil, do no evil: The lessons of immune privilege. Nat Immunol 7:354-359
19. Rosenfeld PJ, Brown DM, Heier JS et al (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419-1431 (Pubitemid 44511557)
20. Sakurai E, Anand A, Ambati BK et al (2003) Macrophage depletion inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 44:3578-3585 (Pubitemid 36909798)
21. Sethi G, Sung B, Aggarwal BB (2008) TNF: A master switch for inflammation to cancer. Front Biosci 13:5094-5107 (Pubitemid 351599660)
22. Taylor PR, Martinez-Pomares L, Stacey M et al (2005) Macrophage receptors and immune recognition. Annu Rev Immunol 23:901-944 (Pubitemid 40563189)
23. Welge-Lussen U, Wilsch C, Neuhardt T et al (1999) Loss of anterior chamber-associated immune deviation (ACAID) in aged retinal degeneration (rd) mice. Invest Ophthalmol Vis Sci 40: 3209-3214
24. van Leeuwen R, Klaver CC, Vingerling JR et al (2003) Epidemiology of age-related maculopathy: A review. Eur J Epidemiol 18:845-854 (Pubitemid 37169020)